Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
Jennifer DeCuir, Amanda B. Payne, Wesley H. Self, Elizabeth A.K. Rowley, Kristin Dascomb, Malini B. DeSilva, Stephanie A. Irving, Shaun J. Grannis, Toan C. Ong, Nicola P. Klein, Zachary A. Weber, Sarah E. Reese, Sarah W. Ball, Michelle A. Barron, Allison L. Naleway, Brian E. Dixon, Inih Essien, Daniel Bride, Karthik Natarajan, Bruce FiremanAmi B. Shah, Erica Okwuazi, Ryan Wiegand, Yuwei Zhu, Adam S. Lauring, Emily T. Martin, Manjusha Gaglani, Ithan D. Peltan, Samuel M. Brown, Adit A. Ginde, Nicholas M. Mohr, Kevin W. Gibbs, David N. Hager, Matthew Prekker, Amira Mohamed, Vasisht Srinivasan, Jay S. Steingrub, Akram Khan, Laurence W. Busse, Abhijit Duggal, Jennifer G. Wilson, Steven Y. Chang, Christopher Mallow, Jennie H. Kwon, Matthew C. Exline, Cristie Columbus, Ivana A. Vaughn, Basmah Safdar, Jarrod M. Mosier, Estelle S. Harris, Jonathan D. Casey, James D. Chappell, Carlos G. Grijalva, Sydney A. Swan, Cassandra Johnson, Nathaniel M. Lewis, Sascha Ellington, Katherine Adams, Mark W. Tenforde, Clinton R. Paden, Fatimah S. Dawood, Katherine E. Fleming-Dutra, Diya Surie, Ruth Link-Gelles
Dive into the research topics of 'Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024'. Together they form a unique fingerprint.